PPARGC1A and neoplasm: We revealed that CAB39L possesses tumor suppressive effects in GC cells, that CAB39L mediates its effect by eliciting an anti-Warburg effect via a LKB1-AMPK-PGC1α axis and that promoter methylation of CAB39L predicts poor outcomes in GC patients.